According to Latest study , the global market for Respiratory Syncytial Virus Diagnostic Testing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Respiratory Syncytial Virus Diagnostic Testing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Respiratory Syncytial Virus Diagnostic Testing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Diagnostic Laboratories grew percent.
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
This report studies and analyses global Respiratory Syncytial Virus Diagnostic Testing status and future trends, to help determine the Respiratory Syncytial Virus Diagnostic Testing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Respiratory Syncytial Virus Diagnostic Testing, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Respiratory Syncytial Virus Diagnostic Testing market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Respiratory Syncytial Virus Diagnostic Testing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Respiratory Syncytial Virus Diagnostic Testing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Respiratory Syncytial Virus Diagnostic Testing key consuming regions, consumption value and demand structure
(5) Respiratory Syncytial Virus Diagnostic Testing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic, Inc.
Luminex Corporation
Agilent Technologies, Inc.
Cepheid (Danaher Corporation)
DiaSorin S.p.A.
Market segment by Type, covers
Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others
Market segment by Application, can be divided into
Hospitals
Diagnostic Laboratories
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Respiratory Syncytial Virus Diagnostic Testing product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Respiratory Syncytial Virus Diagnostic Testing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Respiratory Syncytial Virus Diagnostic Testing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Respiratory Syncytial Virus Diagnostic Testing industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Respiratory Syncytial Virus Diagnostic Testing Definition
1.2 Global Respiratory Syncytial Virus Diagnostic Testing Market Size and Forecast
1.3 China Respiratory Syncytial Virus Diagnostic Testing Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Respiratory Syncytial Virus Diagnostic Testing Market Size: China VS Global Growth Rate, 2018-2029
1.6 Respiratory Syncytial Virus Diagnostic Testing Market Dynamics
1.6.1 Respiratory Syncytial Virus Diagnostic Testing Market Drivers
1.6.2 Respiratory Syncytial Virus Diagnostic Testing Market Restraints
1.6.3 Respiratory Syncytial Virus Diagnostic Testing Industry Trends
1.6.4 Respiratory Syncytial Virus Diagnostic Testing Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Respiratory Syncytial Virus Diagnostic Testing, Global Market Share by Company, 2018-2023
2.2 Global Respiratory Syncytial Virus Diagnostic Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Respiratory Syncytial Virus Diagnostic Testing Concentration Ratio
2.4 Global Respiratory Syncytial Virus Diagnostic Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Respiratory Syncytial Virus Diagnostic Testing Major Companies Product Type
2.6 Head Office and Respiratory Syncytial Virus Diagnostic Testing Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Respiratory Syncytial Virus Diagnostic Testing, China Market Share by Company, 2018-2023
3.2 China Respiratory Syncytial Virus Diagnostic Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Respiratory Syncytial Virus Diagnostic Testing Industry Chain
4.2 Respiratory Syncytial Virus Diagnostic Testing Upstream Analysis
4.2.1 Respiratory Syncytial Virus Diagnostic Testing Core Raw Materials
4.2.2 Main Manufacturers of Respiratory Syncytial Virus Diagnostic Testing Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Respiratory Syncytial Virus Diagnostic Testing Production Mode
4.6 Respiratory Syncytial Virus Diagnostic Testing Procurement Model
4.7 Respiratory Syncytial Virus Diagnostic Testing Industry Sales Model and Sales Channels
4.7.1 Respiratory Syncytial Virus Diagnostic Testing Sales Model
4.7.2 Respiratory Syncytial Virus Diagnostic Testing Typical Distributors
5 Sights by Type
5.1 Respiratory Syncytial Virus Diagnostic Testing Classification
5.1.1 Antigen Detection Test
5.1.2 Molecular Diagnostic Test
5.1.3 Direct Fluorescent Antibody Test
5.1.4 Diagnostic Imaging
5.1.5 Others
5.2 By Type, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029
6 Sights by Application
6.1 Respiratory Syncytial Virus Diagnostic Testing Segment by Application
6.1.1 Hospitals
6.1.2 Diagnostic Laboratories
6.1.3 Others
6.2 By Application, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Respiratory Syncytial Virus Diagnostic Testing & Forecasts, 2018-2029
7.3.2 By Country, North America Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share
7.4 Europe
7.4.1 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share
7.6 South America
7.6.1 South America Respiratory Syncytial Virus Diagnostic Testing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Respiratory Syncytial Virus Diagnostic Testing Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.3.2 By Type, U.S. Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.4.2 By Type, Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.5.2 By Type, China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.6.2 By Type, Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.7.2 By Type, South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.9.2 By Type, India Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 F. Hoffmann-La Roche AG
9.1.1 F. Hoffmann-La Roche AG Company Information, Head Office, Market Area and Industry Position
9.1.2 F. Hoffmann-La Roche AG Company Profile and Main Business
9.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.1.5 F. Hoffmann-La Roche AG Recent Developments
9.2 Abbott
9.2.1 Abbott Company Information, Head Office, Market Area and Industry Position
9.2.2 Abbott Company Profile and Main Business
9.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.2.4 Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.2.5 Abbott Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.3.2 Thermo Fisher Scientific Company Profile and Main Business
9.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.3.5 Thermo Fisher Scientific Recent Developments
9.4 BD (Becton, Dickinson and Company)
9.4.1 BD (Becton, Dickinson and Company) Company Information, Head Office, Market Area and Industry Position
9.4.2 BD (Becton, Dickinson and Company) Company Profile and Main Business
9.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.4.5 BD (Becton, Dickinson and Company) Recent Developments
9.5 QuidelOrtho Corporation
9.5.1 QuidelOrtho Corporation Company Information, Head Office, Market Area and Industry Position
9.5.2 QuidelOrtho Corporation Company Profile and Main Business
9.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.5.5 QuidelOrtho Corporation Recent Developments
9.6 Hologic, Inc.
9.6.1 Hologic, Inc. Company Information, Head Office, Market Area and Industry Position
9.6.2 Hologic, Inc. Company Profile and Main Business
9.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.6.5 Hologic, Inc. Recent Developments
9.7 Luminex Corporation
9.7.1 Luminex Corporation Company Information, Head Office, Market Area and Industry Position
9.7.2 Luminex Corporation Company Profile and Main Business
9.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.7.5 Luminex Corporation Recent Developments
9.8 Agilent Technologies, Inc.
9.8.1 Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Agilent Technologies, Inc. Company Profile and Main Business
9.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.8.5 Agilent Technologies, Inc. Recent Developments
9.9 Cepheid (Danaher Corporation)
9.9.1 Cepheid (Danaher Corporation) Company Information, Head Office, Market Area and Industry Position
9.9.2 Cepheid (Danaher Corporation) Company Profile and Main Business
9.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.9.5 Cepheid (Danaher Corporation) Recent Developments
9.10 DiaSorin S.p.A.
9.10.1 DiaSorin S.p.A. Company Information, Head Office, Market Area and Industry Position
9.10.2 DiaSorin S.p.A. Company Profile and Main Business
9.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications and Application
9.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, 2018-2023
9.10.5 DiaSorin S.p.A. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Respiratory Syncytial Virus Diagnostic Testing Market Restraints
Table 3. Respiratory Syncytial Virus Diagnostic Testing Market Trends
Table 4. Respiratory Syncytial Virus Diagnostic Testing Industry Policy
Table 5. Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Respiratory Syncytial Virus Diagnostic Testing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Respiratory Syncytial Virus Diagnostic Testing Mergers & Acquisitions, Expansion Plans
Table 9. Global Respiratory Syncytial Virus Diagnostic Testing Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Respiratory Syncytial Virus Diagnostic Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing Upstream (Raw Materials)
Table 14. Global Respiratory Syncytial Virus Diagnostic Testing Typical Customers
Table 15. Respiratory Syncytial Virus Diagnostic Testing Typical Distributors
Table 16. By Type, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2018-2029
Table 23. F. Hoffmann-La Roche AG Company Information, Head Office, Market Area and Industry Position
Table 24. F. Hoffmann-La Roche AG Company Profile and Main Business
Table 25. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 26. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. F. Hoffmann-La Roche AG Recent Developments
Table 28. Abbott Company Information, Head Office, Market Area and Industry Position
Table 29. Abbott Company Profile and Main Business
Table 30. Abbott Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 31. Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Abbott Recent Developments
Table 33. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 34. Thermo Fisher Scientific Company Profile and Main Business
Table 35. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 36. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Thermo Fisher Scientific Recent Developments
Table 38. BD (Becton, Dickinson and Company) Company Information, Head Office, Market Area and Industry Position
Table 39. BD (Becton, Dickinson and Company) Company Profile and Main Business
Table 40. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 41. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. BD (Becton, Dickinson and Company) Recent Developments
Table 43. QuidelOrtho Corporation Company Information, Head Office, Market Area and Industry Position
Table 44. QuidelOrtho Corporation Company Profile and Main Business
Table 45. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 46. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. QuidelOrtho Corporation Recent Developments
Table 48. Hologic, Inc. Company Information, Head Office, Market Area and Industry Position
Table 49. Hologic, Inc. Company Profile and Main Business
Table 50. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 51. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Hologic, Inc. Recent Developments
Table 53. Luminex Corporation Company Information, Head Office, Market Area and Industry Position
Table 54. Luminex Corporation Company Profile and Main Business
Table 55. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 56. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Luminex Corporation Recent Developments
Table 58. Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
Table 59. Agilent Technologies, Inc. Company Profile and Main Business
Table 60. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 61. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Agilent Technologies, Inc. Recent Developments
Table 63. Cepheid (Danaher Corporation) Company Information, Head Office, Market Area and Industry Position
Table 64. Cepheid (Danaher Corporation) Company Profile and Main Business
Table 65. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 66. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Cepheid (Danaher Corporation) Recent Developments
Table 68. DiaSorin S.p.A. Company Information, Head Office, Market Area and Industry Position
Table 69. DiaSorin S.p.A. Company Profile and Main Business
Table 70. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Models, Specifications, and Application
Table 71. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. DiaSorin S.p.A. Recent Developments
List of Figures
Figure 1. Respiratory Syncytial Virus Diagnostic Testing Picture
Figure 2. Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Respiratory Syncytial Virus Diagnostic Testing Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Respiratory Syncytial Virus Diagnostic Testing Market Share of Global, 2018-2029
Figure 5. Global Respiratory Syncytial Virus Diagnostic Testing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Respiratory Syncytial Virus Diagnostic Testing Key Participants, Market Share, 2022
Figure 7. Respiratory Syncytial Virus Diagnostic Testing Industry Chain
Figure 8. Respiratory Syncytial Virus Diagnostic Testing Procurement Model
Figure 9. Respiratory Syncytial Virus Diagnostic Testing Sales Model
Figure 10. Respiratory Syncytial Virus Diagnostic Testing Sales Channels, Direct Sales, and Distribution
Figure 11. Antigen Detection Test
Figure 12. Molecular Diagnostic Test
Figure 13. Direct Fluorescent Antibody Test
Figure 14. Diagnostic Imaging
Figure 15. Others
Figure 16. By Type, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 17. By Type, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2018-2029
Figure 18. Hospitals
Figure 19. Diagnostic Laboratories
Figure 20. Others
Figure 21. By Application, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 22. By Application, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2018-2029
Figure 23. By Region, Global Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2018-2029
Figure 24. North America Respiratory Syncytial Virus Diagnostic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, North America Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022
Figure 26. Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022
Figure 28. Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country/Region, Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022
Figure 30. South America Respiratory Syncytial Virus Diagnostic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, South America Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022
Figure 32. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. U.S. Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, U.S. Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 36. Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 39. China Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 42. Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 45. South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 48. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 51. India Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, India Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, India Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 54. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value, 2018-2029, US$ Million
Figure 55. By Type, Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 56. By Application, Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share, 2022 VS 2029
Figure 57. Research Methodology
Figure 58. Breakdown of Primary Interviews
Figure 59. Bottom-up and Top-down Approaches
Figure 60. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|